Myeloperoxidase/ASGPR Dual‐Targeting Self‐Amplifying Nanoplatform for Synergistic Anti‐Metastatic Therapy of Hepatocellular Carcinoma
- DOI
- 10.1002/smll.74938
- Published
- 2026-08-08
- Container
- Small
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/smll.74938,
title = {Myeloperoxidase/ASGPR Dual‐Targeting Self‐Amplifying Nanoplatform for Synergistic Anti‐Metastatic Therapy of Hepatocellular Carcinoma},
author = {Le Wang and Xiang Wang and Hengrui Li and Yihan Ma and Peter H. Seeberger and Jing Hu and Jian Yin},
year = {2026},
journal = {Small},
doi = {10.1002/smll.74938},
url = {https://doi.org/10.1002/smll.74938}
}RIS
TY - JOUR TI - Myeloperoxidase/ASGPR Dual‐Targeting Self‐Amplifying Nanoplatform for Synergistic Anti‐Metastatic Therapy of Hepatocellular Carcinoma AU - Le Wang AU - Xiang Wang AU - Hengrui Li AU - Yihan Ma AU - Peter H. Seeberger AU - Jing Hu AU - Jian Yin PY - 2026 JO - Small DO - 10.1002/smll.74938 UR - https://doi.org/10.1002/smll.74938 ER -
APA
Wang, L., Wang, X., Li, H., Ma, Y., Seeberger, P. H., Hu, J., & Yin, J. (2026). Myeloperoxidase/ASGPR Dual‐Targeting Self‐Amplifying Nanoplatform for Synergistic Anti‐Metastatic Therapy of Hepatocellular Carcinoma. Small. https://doi.org/10.1002/smll.74938
Source records
- crossref · retrieved 2026-09-26T14:04:42.309Z